← Case Library

Clause 26

⚖ 19 PMCPA cases 🔒 Members see all 19 cases

PMCPA Cases — Clause 26

19 cases
📅 8 Mar 2026 · Sanofi

Sanofi breached ABPI Code over Lyxumia cost comparison vs Bydureon in basal-insulin leavepiece (AUTH/2638/9/13, AUTH/2639/9/13)

Clause 26
📅 8 Mar 2026 · Shionogi

Shionogi Europe: LinkedIn posts about Fetcroja ruled pre-licence promotion and public promotion of a POM

Clause 2 Clause 26 Clause 3 Clause 9
📅 8 Mar 2026 · Novartis Pharmaceuticals UK

Novartis: corporate webpage pipeline table ruled to promote POMs to the public and an unlicensed medicine (AUTH/3414/11/20)

Clause 26 Clause 28 Clause 3 Clause 9
🔒

See all 19 cases for Clause 26

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

Already a member? Sign in

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free